fagron semaglutide Weight Loss Blog – Maryland Trim Clinic Semaglutide Weight Loss Injections |

In June 2021, The Food and Drug Administration (FDA) approved semaglutide for the treatment of overweight with at least one weight-related condition such as diabetes, high blood pressure or high cholesterol and obesity

Davies MJ, Aronne LJ, Caterson ID, Thomsen AB, Jacobsen PB, Marso SP, et al

Whilst GLP-1 medications do not directly alter reproductive hormones, the significant weight loss they facilitate can indirectly influence period regularity through well-established metabolic pathways

Wolffenbuttel BHR, Brugts MP, Catarig AM, et al

World Health Organization 2020 guidelines on physical activity and sedentary behaviour